BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31740695)

  • 1. VAR2CSA binding phenotype has ancient origin and arose before Plasmodium falciparum crossed to humans: implications in placental malaria vaccine design.
    Gangnard S; Chêne A; Dechavanne S; Srivastava A; Avril M; Smith JD; Gamain B
    Sci Rep; 2019 Nov; 9(1):16978. PubMed ID: 31740695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA.
    Pinto VV; Ditlev SB; Jensen KE; Resende M; Dahlbäck M; Andersen G; Andersen P; Theander TG; Salanti A; Nielsen MA
    PLoS One; 2011 Mar; 6(3):e17942. PubMed ID: 21464946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antibody response of pregnant Cameroonian women to VAR2CSA ID1-ID2a, a small recombinant protein containing the CSA-binding site.
    Babakhanyan A; Leke RG; Salanti A; Bobbili N; Gwanmesia P; Leke RJ; Quakyi IA; Chen JJ; Taylor DW
    PLoS One; 2014; 9(2):e88173. PubMed ID: 24505415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates.
    Doritchamou JYA; Renn JP; Jenkins B; Mahamar A; Dicko A; Fried M; Duffy PE
    Elife; 2022 Feb; 11():. PubMed ID: 35103596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria Vaccine.
    Nielsen MA; Resende M; de Jongh WA; Ditlev SB; Mordmüller B; Houard S; Ndam NT; Agerbæk MØ; Hamborg M; Massougbodji A; Issifou S; Strøbæk A; Poulsen L; Leroy O; Kremsner PG; Chippaux JP; Luty AJ; Deloron P; Theander TG; Dyring C; Salanti A
    PLoS One; 2015; 10(9):e0135406. PubMed ID: 26327283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing a VAR2CSA-based vaccine to prevent placental malaria.
    Fried M; Duffy PE
    Vaccine; 2015 Dec; 33(52):7483-8. PubMed ID: 26469717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the DBL3X-DBL4ε region of the VAR2CSA placental malaria vaccine candidate: insight into DBL domain interactions.
    Gangnard S; Lewit-Bentley A; Dechavanne S; Srivastava A; Amirat F; Bentley GA; Gamain B
    Sci Rep; 2015 Oct; 5():14868. PubMed ID: 26450557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates.
    Avril M; Hathaway MJ; Srivastava A; Dechavanne S; Hommel M; Beeson JG; Smith JD; Gamain B
    PLoS One; 2011 Feb; 6(2):e16622. PubMed ID: 21326877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic diversity of VAR2CSA ID1-DBL2Xb in worldwide Plasmodium falciparum populations: impact on vaccine design for placental malaria.
    Bordbar B; Tuikue Ndam N; Renard E; Jafari-Guemouri S; Tavul L; Jennison C; Gnidehou S; Tahar R; Gamboa D; Bendezu J; Menard D; Barry AE; Deloron P; Sabbagh A
    Infect Genet Evol; 2014 Jul; 25():81-92. PubMed ID: 24768682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating antibody functional activity and strain-specificity of vaccine candidates for malaria in pregnancy using in vitro phagocytosis assays.
    Hommel M; Chan JA; Umbers AJ; Langer C; Rogerson SJ; Smith JD; Beeson JG
    Parasit Vectors; 2018 Jan; 11(1):69. PubMed ID: 29378634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel adenovirus encoded virus-like particles displaying the placental malaria associated VAR2CSA antigen.
    Andersson AC; Resende M; Salanti A; Nielsen MA; Holst PJ
    Vaccine; 2017 Feb; 35(8):1140-1147. PubMed ID: 28131394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing expression of the pregnancy malaria vaccine candidate, VAR2CSA in Pichia pastoris.
    Avril M; Hathaway MJ; Cartwright MM; Gose SO; Narum DL; Smith JD
    Malar J; 2009 Jun; 8():143. PubMed ID: 19563628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional insight into how the Plasmodium falciparum VAR2CSA protein mediates binding to chondroitin sulfate A in placental malaria.
    Clausen TM; Christoffersen S; Dahlbäck M; Langkilde AE; Jensen KE; Resende M; Agerbæk MØ; Andersen D; Berisha B; Ditlev SB; Pinto VV; Nielsen MA; Theander TG; Larsen S; Salanti A
    J Biol Chem; 2012 Jul; 287(28):23332-45. PubMed ID: 22570492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for globally shared, cross-reacting polymorphic epitopes in the pregnancy-associated malaria vaccine candidate VAR2CSA.
    Avril M; Kulasekara BR; Gose SO; Rowe C; Dahlbäck M; Duffy PE; Fried M; Salanti A; Misher L; Narum DL; Smith JD
    Infect Immun; 2008 Apr; 76(4):1791-800. PubMed ID: 18250177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of strain-transcendent antibodies to placental-type isolates with VAR2CSA DBL3 or DBL5 recombinant proteins.
    Avril M; Cartwright MM; Hathaway MJ; Smith JD
    Malar J; 2011 Feb; 10():36. PubMed ID: 21314945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chondroitin sulfate A-binding site of the VAR2CSA protein involves multiple N-terminal domains.
    Dahlbäck M; Jørgensen LM; Nielsen MA; Clausen TM; Ditlev SB; Resende M; Pinto VV; Arnot DE; Theander TG; Salanti A
    J Biol Chem; 2011 May; 286(18):15908-17. PubMed ID: 21398524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chondroitin sulfate A-adhering Plasmodium falciparum-infected erythrocytes express functionally important antibody epitopes shared by multiple variants.
    Barfod L; Dobrilovic T; Magistrado P; Khunrae P; Viwami F; Bruun J; Dahlbäck M; Bernasconi NL; Fried M; John D; Duffy PE; Salanti A; Lanzavecchia A; Lim CT; Ndam NT; Higgins MK; Hviid L
    J Immunol; 2010 Dec; 185(12):7553-61. PubMed ID: 21078904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Id1-DBL2X of VAR2CSA as a key domain inducing highly inhibitory and cross-reactive antibodies.
    Bordbar B; Tuikue-Ndam N; Bigey P; Doritchamou J; Scherman D; Deloron P
    Vaccine; 2012 Feb; 30(7):1343-8. PubMed ID: 22226864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with VAR2CSA-DBL5 recombinant protein elicits broadly cross-reactive antibodies to placental Plasmodium falciparum-infected erythrocytes.
    Avril M; Cartwright MM; Hathaway MJ; Hommel M; Elliott SR; Williamson K; Narum DL; Duffy PE; Fried M; Beeson JG; Smith JD
    Infect Immun; 2010 May; 78(5):2248-56. PubMed ID: 20194590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine Model for Preclinical Studies of Var2CSA-Mediated Pathology Associated with Malaria in Pregnancy.
    de Moraes LV; Dechavanne S; Sousa PM; Barateiro A; Cunha SF; Nunes-Silva S; Lima FA; Murillo O; Marinho CRF; Gangnard S; Srivastava A; Braks JA; Janse CJ; Gamain B; Franke-Fayard B; Penha-Gonçalves C
    Infect Immun; 2016 Jun; 84(6):1761-1774. PubMed ID: 27045035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.